Overall, insufficient IL-15 levels and decreased responsiveness of CD4+CD25+CD127dim/− Tregs to IL-15 signaling might contribute to the immune dysfunction in CHB patients with T2DM. The gene discussed is IL15; the disease is immune system disorder.